Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Xiongbin Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7987-9825; OpenAlex author ID A5081753593. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 6

  1. Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. Co-author DOI 10.1002/adma.202520546↗
  2. Corrigendum to Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci211838↗
  3. Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1038/s41467-025-63146-2↗
  4. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci187024↗
  5. A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy. Last author DOI 10.1002/advs.202300548↗
  6. Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer. Co-author DOI 10.1200/cci.21.00124↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kang Sun · 3 shared papers, 2025–2026 · strength 0.55
  2. Mengyi Lao · 3 shared papers, 2025–2026 · strength 0.55
  3. Xiao Zhi · 2 shared papers, 2025–2026 · strength 0.37
  4. Mao Ye · 2 shared papers, 2025–2026 · strength 0.37
  5. Jinyuan Song · 2 shared papers, 2025–2026 · strength 0.37
  6. Hanshen Yang · 2 shared papers, 2025 · strength 0.36
  7. Lihong He · 2 shared papers, 2025 · strength 0.36
  8. Lingyue Liu · 2 shared papers, 2025 · strength 0.36
  9. Tingbo Liang · 2 shared papers, 2025 · strength 0.36
  10. Xueli Bai · 2 shared papers, 2025 · strength 0.36
  11. Tianan Jiang · 1 shared paper, 2026 · strength 0.26
  12. Chengyue Zhang · 1 shared paper, 2026 · strength 0.26
  13. Tingbo Liang · 1 shared paper, 2026 · strength 0.20
  14. Junming Huang · 1 shared paper, 2025 · strength 0.19
  15. Xinyuan Liu · 1 shared paper, 2025 · strength 0.19
  16. Yan Chen · 1 shared paper, 2025 · strength 0.19
  17. Xiaozhen Zhang · 1 shared paper, 2025 · strength 0.19
  18. Chuanpeng Dong · 1 shared paper, 2022 · strength 0.17
  19. Yunlong Liu · 1 shared paper, 2022 · strength 0.17
  20. Xiang Li Ma · 1 shared paper, 2025 · strength 0.17
  21. Zhuolong Zhou · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.